Loan & DebtSep 8, 2026, 06:02 AM
Vivos Therapeutics Exchanges $2.86M Debt for 11.45M Shares
AI Summary
Vivos Therapeutics, Inc. entered into twelve exchange agreements with Streeterville Capital, LLC to partition $2,861,270.00 of the outstanding principal balance of the Streeterville Note into twelve separate secured promissory notes. These Partitioned Notes will be exchanged for an aggregate of up to 11,445,080 shares of Vivos' common stock, at an average exchange price of $0.25 per share. This transaction aims to reduce the company's outstanding debt.
Key Highlights
- Vivos Therapeutics exchanged $2.86M of its outstanding Streeterville Note for up to 11.45M shares of common stock.
- The exchange price per share was an average of $0.25, meeting Nasdaq's Minimum Price rule.
- Streeterville Capital will receive up to 11,445,080 shares of common stock in exchange for $2,861,270.00 of the principal.
- The company previously satisfied $975,000 of redemption obligations with 785,822 shares between Dec 2025 and May 2026.
- On August 4, 2026, $3.25M of the note was exchanged for Series B Preferred Stock and 1.81M common shares.
Price Impact
More from VVOS